a PK (Kaletra 133.3 mg / 33.3 mg)

Generic Name: lopinavir/ritonavir

Pill imprint a PK has been identified as Kaletra 133.3 mg / 33.3 mg.

Kaletra is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Kaletra 133.3 mg / 33.3 mg is not a controlled substance under the Controlled Substance Act (CSA).

Kaletra

Generic Name:

lopinavir/ritonavir

Imprint:

a PK

Strength:

133.3 mg / 33.3 mg

Color:

Orange

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Protease inhibitors

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Abbott Laboratories

National Drug Code (NDC):

00074-3959

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.